AN EYEDROP FOR CATARACT?

According to this press release:

"AlphaRX, an emerging biopharmaceutical company ...is pleased to announce that the development of the formulation for Acusolin™, ...has been completed and in vivo studies are underway as scheduled.

"The Company will investigate Acusolin™ using an established cataract animal model. This model is designed to demonstrate Acusolin™'s ability to prevent and treat senile cataracts."

I'll believe it when I see it.